JW Pharmaceutical Corporation (KRX:001060)
South Korea flag South Korea · Delayed Price · Currency is KRW
32,200
+1,200 (3.87%)
Apr 10, 2026, 3:30 PM KST

JW Pharmaceutical Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
735,104584,933561,695828,523419,688505,678
Market Cap Growth
42.03%4.14%-32.20%97.41%-17.00%-32.85%
Enterprise Value
728,397571,085600,784959,912491,395649,827
Last Close Price
32200.0024967.9023499.2034154.1717093.9720225.75
PE Ratio
12.719.518.6422.3913.16-
PS Ratio
0.950.750.781.110.610.83
PB Ratio
1.991.581.713.121.862.68
P/TBV Ratio
2.061.641.763.291.842.68
P/FCF Ratio
8.696.917.9013.848.9647.45
P/OCF Ratio
7.636.077.089.517.3927.90
EV/Sales Ratio
0.940.740.841.280.721.07
EV/EBITDA Ratio
6.695.365.908.056.3613.84
EV/EBIT Ratio
8.086.507.269.938.1221.07
EV/FCF Ratio
8.616.758.4516.0310.4960.98
Debt / Equity Ratio
0.150.150.280.640.931.30
Debt / EBITDA Ratio
0.510.510.901.432.715.22
Debt / FCF Ratio
0.650.651.292.844.4723.00
Net Debt / Equity Ratio
-0.02-0.020.180.290.270.95
Net Debt / EBITDA Ratio
-0.06-0.060.580.640.773.82
Net Debt / FCF Ratio
-0.08-0.080.831.271.2816.84
Asset Turnover
1.281.281.151.181.091.03
Inventory Turnover
3.753.753.643.793.703.65
Quick Ratio
0.860.860.820.900.800.79
Current Ratio
1.421.421.471.321.121.30
Return on Equity (ROE)
17.60%17.60%21.87%15.65%14.41%-0.73%
Return on Assets (ROA)
9.08%9.08%8.28%9.49%6.00%3.26%
Return on Invested Capital (ROIC)
17.31%16.20%17.88%21.60%12.18%-0.62%
Return on Capital Employed (ROCE)
22.20%22.20%20.90%27.00%24.40%8.80%
Earnings Yield
8.37%10.52%11.58%4.47%7.60%-0.19%
FCF Yield
11.51%14.47%12.65%7.23%11.16%2.11%
Payout Ratio
17.99%17.99%14.86%23.82%23.05%-
Buyback Yield / Dilution
1.32%1.32%-3.34%-2.49%-0.07%0.05%
Total Shareholder Return
2.86%1.32%-3.34%-2.49%-0.07%0.05%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.